1 in 8 recovered COVID-19 patients dies within 5 months: study
Almost a third of recovered COVID-19 patients end up back in hospital within five months – and according to one report, up to one in eight dies from complications from the disease.
Researchers at Leicester University in the United Kingdom and the Office for National Statistics found that of 47,780 people discharged from hospital, 29.4 percent were readmitted within 140 days, the Telegraph reported.
Of the total number, 12.3 percent succumbed to the disease.
According to the report, many people with long-term effects of the coronavirus develop heart problems, diabetes, and chronic liver and kidney disease.
“People seem to go home, have long-term effects, come back in and die. We see that almost 30 percent have been resumed, and that is a lot of people. The numbers are so big, ”said study author Kamlesh Khunti.
“The message here is that we really need to prepare for long COVID. Caring for these patients is a mammoth job and the NHS is really on the rise right now, but some sort of surveillance needs to be arranged, ”added Khunti, professor of diabetes in primary care and vascular medicine at Leicester University.
The study, which identified Khunti as the largest person discharged from hospital after being admitted with COVID-19, found that survivors were re-admitted and died almost three and a half times more often than other outpatients in 140 days.
Khunti said researchers were surprised that many people were re-admitted with a new diagnosis, adding that it was important to make sure people are receiving protective therapies, including statins and aspirin.
“We don’t know if it’s because COVID is destroying the beta cells that make insulin and you get type 1 diabetes, or if it causes insulin resistance and you develop type 2, but we’re seeing these surprising new ones Diagnoses of diabetes, “he said.
“We’ve seen studies where survivors had MRS scans and had heart and liver problems,” added Khunti. “These people urgently need follow-up examinations and deal with things like aspirin and statins.”
The new study was published on a pre-print server and has not yet been peer-reviewed.